FIELD: chemistry.
SUBSTANCE: invention relates to compounds of general formula (I), where Y is selected from -CRay=CRby- and -CHRay-CRby=CRcy-; each Ray, Rby and Rcy is independently selected from a hydrogen atom and unsubstituted C1-C12 alkyl; each R1, R2, R3, R4 and R5 is independently selected from a hydrogen atom and unsubstituted C1-C12 alkyl; R6 is selected from NR8R9 and OR10; W is selected from NR7; R7 is a hydrogen atom; R8 is a hydrogen atom; R10 is an unsubstuted C2-C12 alkenyl; R9 is a substituted C2-C12 alkenyl which is substituted in one or more positions by a halogen , OR', OCONHR' and OH, protected by a silyl ether, where R' is hydrogen; each of R11, R12, R13, R14 and R15 is independently selected from a hydrogen atom, ORa, OSiRaRbRc; and each Ra, Rb and Rc is independently selected from a hydrogen atom and unsubstituted C1-C12 alkyl. The invention also relates to a pharmaceutical composition having cytotoxic activity, which contains said compounds, use of compounds of formula (I) to prepare a medicinal agent for treating cancer and methods of producing compounds of formula (I).
EFFECT: compounds having cytotoxic activity.
23 cl, 10 dwg, 2 tbl, 10 ex
Title | Year | Author | Number |
---|---|---|---|
ANTITUMOUR COMPOUNDS | 2008 |
|
RU2528393C9 |
ANTITUMORAL COMPOUNDS | 2008 |
|
RU2489429C2 |
ANTICANCER DIHYDROPYRAN-3-ONE COMPOUNDS | 2007 |
|
RU2444519C2 |
ANTITUMOR LAMELLARIN ANALOGS | 2003 |
|
RU2328500C2 |
COMPOSITIONS AND METHODS OF TREATMENT OF DISEASES OF CENTRAL NERVOUS SYSTEM | 2018 |
|
RU2810331C2 |
COMPOSITIONS AND METHODS OF THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM | 2018 |
|
RU2799448C2 |
NEUROACTIVE STEROIDS AND METHODS OF THEIR USE | 2014 |
|
RU2808166C2 |
NEUROACTIVE STEROIDS AND METHODS FOR USE THEREOF | 2014 |
|
RU2684103C2 |
GENERAL SYNTHESIS OF MYRIAPORONES | 2003 |
|
RU2328492C2 |
ANTIBODY DRUG CONJUGATES | 2014 |
|
RU2669812C2 |
Authors
Dates
2013-09-20—Published
2008-12-19—Filed